Straight from the Desk
Syz the moment
Live feeds, charts, breaking stories, all day long.
- All
- equities
- United States
- Macroeconomics
- Food for Thoughts
- markets
- Central banks
- Fixed Income
- bitcoin
- Asia
- europe
- investing
- technical analysis
- geopolitics
- gold
- Crypto
- AI
- Commodities
- Technology
- nvidia
- ETF
- earnings
- Forex
- china
- Real Estate
- banking
- oil
- Volatility
- magnificent-7
- energy
- apple
- Alternatives
- emerging-markets
- switzerland
- tesla
- United Kingdom
- Middle East
- assetmanagement
- amazon
- russia
- ethereum
- microsoft
- ESG
- meta
- Industrial-production
- bankruptcy
- Healthcare
- Turkey
- Global Markets Outlook
- africa
- Market Outlook
- brics
Almost everyone is all-in on the Mag7 stocks
169 surveyed fund managers with $413 billion in assets said in August that the 'Long Magnificent 7' is the most crowded trade. Professionals, foreigners, and retail investors are heavily invested in these stocks. Source: Global Markets Investor, BofA
U.S. Treasury volatility falls to its lowest level since January 2022
No Fear left in the market! Source: Barchart
Currency debasement is not a bug — it’s a feature of the fiat system.
Since Bretton Woods collapsed in 1971, not one of 152 countries has kept average inflation below 2%. Even Switzerland averaged 2.2%. Source: Global Markets Investors
The Goldman Sachs AI Leaders Basket
Consisting of the 9 leading AI stocks (semiconductors: Nvidia, TSMC), software/data center (Palantir, Oracle, Microsoft, Vertiv), and power/infrastructure (GE Vernova, Constellation, Vistra) has made 756% since ChatGPT launch in 2022, an avg of 122% per year! Source: Bloomberg, HolderZ
Some very important charts...
Goldman Sachs find that US import prices on tariffed goods have declined somewhat, suggesting that foreign exporters have absorbed some tariff costs by lowering their export prices to the US, unlike during the 2018-2019 trade war. Source: Goldman Sachs thru Mike Zaccardi, CFA, CMT, MBA
Investing with intelligence
Our latest research, commentary and market outlooks

